Landriscina, Matteo <br/><br/>
Targeting epidermal growth factor receptor 1 signaling in human thyroid-stimulating hormone-independent thyroid carcinoma FRO cells results in a more chemosensitive and less angiogenic phenotype.  [electronic resource] 

 -  Thyroid : official journal of the American Thyroid Association  Jun 2009 
 - 629-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-9077 
<br/><br/><label>Standard No.: </label>10.1089/thy.2008.0355  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Blotting, Western<br/>Cell Differentiation--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Survival--drug effects<br/>Down-Regulation--drug effects<br/>Drug Resistance, Neoplasm<br/>ErbB Receptors--biosynthesis<br/>Humans<br/>Microscopy, Confocal<br/>Neovascularization, Pathologic--pathology<br/>Phenotype<br/>RNA, Neoplasm--biosynthesis<br/>S Phase--drug effects<br/>Signal Transduction--drug effects<br/>Tetrazolium Salts<br/>Thiazoles<br/>Thyroid Neoplasms--drug therapy<br/>Thyrotropin--physiology